Citation Impact

Citing Papers

Carboplatin dosage: prospective evaluation of a simple formula based on renal function.
1989 Standout
Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation
2004 StandoutNobel
Enzymes acting at strand interruptions in DNA
1995 StandoutNobel
Teratocarcinomas and human embryology: Pluripotent human EC cell lines
1998
Testicular Germ-Cell Cancer
1997 Standout
Therapeutic Drug Monitoring in Oncology
1987
Acute axonal Guillain‐Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides
1995
Effect of Gender on the Progression of Nondiabetic Renal Disease
2000
Clinical concordance in sibling pairs with multiple sclerosis
1996
GM1b is a new member of antigen for serum antibody in Guillain-Barre syndrome
1996
Pathogenesis and therapy of neuropathies associated with monoclonal gammopathies
1995
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
Cancer in patients on dialysis for end-stage renal disease: an international collaborative study
1999 Standout
Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative.
1996 Standout
HLA Has Strongest Association with IgA Nephropathy in Genome-Wide Analysis
2010 StandoutNobel
Guillain-Barré syndrome
2016 Standout
Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis
2016 Standout
Anti–GM1 IgG antibodies induce leukocyte effector functions via Fcγ receptors
2003
A common mechanism and a new categorization for anti-ganglioside antibody-mediated neuropathies
2012
Multiple sclerosis
2008 Standout
Increased plasma viscosity as a reason for inappropriate erythropoietin formation.
1993 StandoutNobel
Effectiveness of carboplatin, etoposide, and bleomycin combination chemotherapy in good-prognosis metastatic testicular nonseminomatous germ cell tumors.
1991
Campylobacter jejuni infections and anti‐GM1 antibodies in guillain‐barré syndrome
1996
The Influence of Finasteride on the Development of Prostate Cancer
2003 Standout
N‐acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain‐Barré syndrome
1994
The clinical correlates of high‐titer IgG anti‐GM1 antibodies
1994
Enzymic release of 5'-terminal deoxyribose phosphate residues from damaged DNA in human cells
1991 StandoutNobel
Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro
2000 Standout
Nodo-paranodopathy: Beyond the demyelinating and axonal classification in anti-ganglioside antibody-mediated neuropathies
2013
Monoclonal IgM antibodies to GM1 and asialo‐GM1 in chronic neuropathies cross‐react with Compylobacter jejuni lipopolysaccharides
1994
Immunopathogenesis and treatment of the guillain‐barré syndrome—part I
1995
Antibodies to gangliosides and galactocerebroside in patients with Guillain–Barré syndrome with preceding Campylobacter jejuni and other identical infections
1998
Effects of cisplatin on different measures of glomerular function in the human kidney with special emphasis on high-dose
1988
Antibodies to GT1a ganglioside in patients with Guillain–Barré syndrome
1998
Strategies to Improve Long-Term Outcomes after Renal Transplantation
2002 Standout
Complement
2001 Standout
Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain‐Barré syndrome and controls: Correlation and prognosis
1993
Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome
1996
Anti‐ganglioside GM1 antibodies in guillain‐barré syndrome and their relationship to Campylobacter jejuni infection
1995
Infection in Solid-Organ Transplant Recipients
2007 Standout
Merging homogeneous catalysis with biocatalysis; papain as hydrogenation catalyst
2005 StandoutNobel
Impaired gut function as risk factor for invasive candidiasis in neutropenic patients
2002
Pathogenesis of Guillain–Barré syndrome
1999
Amyotrophic Lateral Sclerosis
2001 Standout
Infection in Organ-Transplant Recipients
1998 Standout
Increased serum levels of β2m‐free HLA class I heavy chain in multiple myeloma
1999
Guillain-Barré syndrome
2005 Standout
Positron emission tomography evaluation of residual radiographic abnormalities in postchemotherapy germ cell tumor patients.
1996
The human embryonal carcinoma marker antigen TRA-1-60 is a sialylated keratan sulfate proteoglycan.
1999
Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the Prostate
1987 Standout
Structure of Papain
1968 Nature
Structural patterns in globular proteins
1976 StandoutNatureNobel
Bioorganometallic Chemistry of Ferrocene
2004 Standout
Induction of anti-GM1 ganglioside antibodies by Campylobacter jejuni lipopolysaccharides
1997
Partial H (?1H) deficiency and glomerulonephritis in two families
1982
Hypomagnesemia, renal dysfunction, and Raynaud's phenomenon in patients treated with cisplatin, vinblastine, and bleomycin
1985
Active site and complete sequence of the suicidal methyltransferase that counters alkylation mutagenesis.
1985 StandoutNobel
Determination of the secondary structures of proteins by circular dichroism and optical rotatory dispersion
1972 Standout
Isolation and properties of a protein from chloroplasts required for phosphorylation and hydrogen ion uptake
1969
Conformational parameters for amino acids in helical, β-sheet, and random coil regions calculated from proteins
1974 Standout
Effects of permeant buffers on the initial time course of photophosphorylation and postillumination phosphorylation.
1980 StandoutNobel
Familial IgA Nephropathy
1985
X-ray studies of crystalline proteins
1969
Excision of Pyrimidine Dimers from Ultraviolet‐Irradiated DNA by Exonucleases from Mammalian Cells
1971 StandoutNobel
The Current Status and Future Prospects of Treatment for Multiple Myeloma
1982
Two patterns of clinical recovery in Guillain-Barre syndrome with IgG anti-GM1 antibody
1998
A simplified representation of protein conformations for rapid simulation of protein folding
1976 StandoutNobel
TREATMENT OF EXCESSIVE AXILLARY SWEATING
1974 Standout
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Prognostic value of pretreatment serum beta 2 microglobulin in myeloma: a Southwest Oncology Group Study [see comments]
1990
Molecular cloning of a bovine cathepsin
1985 StandoutNobel
Structure and mechanism in the enzymic activity of carboxypeptidase A and relations to chemical sequence
1970 StandoutNobel
Automatic identification of secondary structure in globular proteins
1977 StandoutNobel
Solvent content of protein crystals
1968 Standout
Heavy-atom sulphydryl derivatives of ox haemoglobin and β lactoglobulin; factors affecting isomorphism of native and derivative crystals
1966
Clinical features and pathophysiological basis of sensory neuronopathies (ganglionopathies)
2004
Gene-Targeted Mice Lacking the Trex1 (DNase III) 3′→5′ DNA Exonuclease Develop Inflammatory Myocarditis
2004 StandoutNobel
Evolution of the Management of Stage I Nonseminomatous Germ-cell Tumors of the Testis
1991
Prostatic Acid Phosphatase: Its Current Clinical Status
1987
The Action Pattern of Mammalian Deoxyribonuclease IV
1971 StandoutNobel
Multifocal motor neuropathy: Diagnostic criteria that predict the response to immunoglobulin treatment
2000
Structure, Recognition, and Processing of Cisplatin−DNA Adducts
1999 Standout
Anti-GalNAc-GD1a antibody-associated Guillain-Barré syndrome with a predominantly distal weakness without cranial nerve impairment and sensory disturbance
1999
Isolation of a Cytochrome b6-f Particle from Chloroplasts
1972
Phase variation of a β‐1,3 galactosyltransferase involved in generation of the ganglioside GM1‐like lipo‐oligosaccharide of Campylobacter jejuni
2000
Possible molecular mechanisms of the protonmotive function of cytochrome systems
1976 StandoutNobel
Lipopolysaccharide Endotoxins
2002 Standout
Axonal Guillain-Barr� syndrome: Relation to anti-ganglioside antibodies andCampylobacter jejuni infection in Japan
2000
A High Resolution Structure of an Inhibitor Complex of the Extracellular Nuclease of Staphylococcus aureus
1971 StandoutNobel
The Structure of Papain
1971 Standout
Prognostic Factors in Survival Free of Progression After Androgen Deprivation Therapy for Treatment of Prostate Cancer
1989
HMG-domain proteins specifically inhibit the repair of the major DNA adduct of the anticancer drug cisplatin by human excision nuclease.
1994 StandoutNobel
Specific Lymphocyte Stimulation by Purified, Heat-inactivated Hepatitis-B Antigen
1973
Structural and functional homology between mammalian DNase IV and the 5'-nuclease domain of Escherichia coli DNA polymerase I.
1994 StandoutNobel
Prediction of protein conformation
1974 Standout
Prognostic value of pretreatment serum beta 2 microglobulin in myeloma: a Southwest Oncology Group Study [see comments]
1990
The Purification of Papain by Affinity Chromatography
1970 StandoutNobel
Immunoglobulin subclass distribution and binding characteristics of anti-GQ1b antibodies in Miller fisher syndrome
1994
Cisplatin
1984 Standout
International Staging System for Multiple Myeloma
2005 Standout

Works of J. Marrink being referenced

Importance of a new tumor market TRA-1-60 in the follow-up of patients with clinical stage I nonseminomatous testicular germ cell tumors
1997
Aggressive chemotherapy for acute leukaemia frequently causes intestinal protein leakage
1991
Results of adjuvant surgery in patients with stage III and IV nonseminomatous testicular tumors after cisplatin‐vinblastine‐bleomycin chemotherapy
1988
Complement activation during an active cytomegalovirus infection after renal transplantation: Due to circulating immune complexes or alternative pathway activation?
1989
Detection of recurrence in patients with clinical stage I nonseminomatous testicular germ cell tumors and consequences for further follow-up: a single-center 10-year experience.
1995
Tra‐1‐60: A new serum marker in patients with germ‐cell tumors
1991
The clinical course of IgA nephropathy in adults.
1977
Orchidectomy alone in stage I nonseminomatous testicular germ cell tumors
1987
Proteolytic activity at neutral pH in bovine spleen
1968
Anti-GM1 antibodies in patients with Guillain-Barre syndrome.
1992
Serum beta2‐microglobulin: a real improvement in the management of multiple myeloma?
1985
Prostatic Acid Phosphatase: Comparison of Radioimmunoassay and Enzyme Activity Assay
1983
The Use of an Immunoadsorbent in the Isolation of Australia Antigen
1973
The crystal structure of papain C
1962
Vindesine therapy in melphalan-resistant multiple myeloma
1981
Some effects of combination chemotherapy with cis-platinum on renal function in patients with nonseminomatous testicular carcinoma
1983
Molecular weight determination by chromatography on sepharose 4B
1969
Anti-sulphatide antibodies in peripheral neuropathy.
1993
Rankless by CCL
2026